Very pleased to discuss the excellent trial results of Invex Therapeutics (IXC:ASX) in todays podcast. This is a key holding of the FiftyOne Capital Progressive Global Fund.
Published 22 May 2020
The FiftyOne Capital Podcast is a series of audio updates on global markets, how the fund is positioned, or any variety of topics we feel could be of benefit to our investors. If you wish to contact us, visit our website at www.fiftyonecapital.com or contact us on firstname.lastname@example.org The information in this podcast is strictly general in nature and is not advice or based on your personal situation. Do your own research.